Bing

SEARCH HISTORY

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Spectrum Pharmaceuticals ( SPPI) as a strong on ...
The Street · 5/12/2015
Spectrum Pharmaceuticals, Inc. (SPPI) was a big mover last session, as its shares rose over 10% on the day. The upside came on the back of an encouraging announcement by an activist that the company could fetch more than $7.95 a share in a sale.
Yahoo Finance · 5/13/2015
Over the last 30 days, the company witnessed two negative estimate revisions and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move …
ZACKS · 5/13/2015
More from Bing News
Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks from a “buy” rating to a “hold” rating in a note issued to investors on Friday. Zacks’ analyst wrote, “Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing …
Mideast Times · 5/9/2015
Second place goes to Spectrum Pharmaceuticals Inc. SPPI, +6.69% which focuses on developing and acquiring ... backing up analysts’ support for the stock. The company expects first-quarter revenue to range from …
Market Watch · 5/12/2015
stock market
Spectrum Pharma (NASDAQ: SPPI) 7.4% HIGHER; investors seek sale of company YY ... including net proceeds of $100.7 million from the common stock offering in January 2015. Juniper Networks (NYSE: JNPR) 0.
StreetInsider · 5/12/2015
Armistice Capital, LLC (“we”) beneficially owns 5.4% of the outstanding shares of SPPI. We are a long-term shareholder of the Company. Recent events and underperformance necessitate intervention. As of …
Value Walk · 5/12/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. Zacks’ analyst wrote, “Spectrum Pharmaceuticals, Inc. is opportunistically ...
Ticker Report · 5/8/2015
Spectrum Pharmaceuticals (NASDAQ:SPPI) posted its quarterly earnings results on Thursday. The company reported ($0.07) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.06) by $0.01, Stock Ratings Network.com reports.
sleekmoney.com · 5/7/2015
The company’s quarterly revenue was down 3.7% on a year-over-year basis. Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) traded down 4.41% on Friday, hitting $5.63. The stock had a trading volume of 883,225 shares. Spectrum Pharmaceuticals …
wkrb13.com · 5/8/2015
Related Searches